Unknown

Dataset Information

0

Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.

ABSTRACT: We previously reported that a single immunization with an adenovirus serotype 26 (Ad26)-vector-based vaccine expressing an optimized SARS-CoV-2 spike (Ad26.COV2.S) protected rhesus macaques against SARS-CoV-2 challenge. To evaluate reduced doses of Ad26.COV2.S, 30 rhesus macaques were immunized once with 1 × 1011, 5 × 1010, 1.125 × 1010, or 2 × 109 viral particles (vp) Ad26.COV2.S or sham and were challenged with SARS-CoV-2. Vaccine doses as low as 2 × 109 vp provided robust protection in bronchoalveolar lavage, whereas doses of 1.125 × 1010 vp were required for protection in nasal swabs. Activated memory B cells and binding or neutralizing antibody titers following vaccination correlated with protective efficacy. At suboptimal vaccine doses, viral breakthrough was observed but did not show enhancement of disease. These data demonstrate that a single immunization with relatively low dose of Ad26.COV2.S effectively protected against SARS-CoV-2 challenge in rhesus macaques, although a higher vaccine dose may be required for protection in the upper respiratory tract.

SUBMITTER: He X 

PROVIDER: S-EPMC8166510 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

We previously reported that a single immunization with an adenovirus serotype 26 (Ad26)-vector-based vaccine expressing an optimized SARS-CoV-2 spike (Ad26.COV2.S) protected rhesus macaques against SARS-CoV-2 challenge. To evaluate reduced doses of Ad26.COV2.S, 30 rhesus macaques were immunized once with 1 × 10<sup>11</sup>, 5 × 10<sup>10</sup>, 1.125 × 10<sup>10</sup>, or 2 × 10<sup>9</sup> viral particles (vp) Ad26.COV2.S or sham and were challenged with SARS-CoV-2. Vaccine doses as low as 2 ×  ...[more]

Similar Datasets

Unknown SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.
| S-EPMC8497464 | biostudies-literature
Unknown Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN.
| S-EPMC9683731 | biostudies-literature
Unknown Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques.
| S-EPMC10040355 | biostudies-literature
Unknown Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques.
| S-EPMC9020736 | biostudies-literature
Unknown Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
| S-EPMC7581548 | biostudies-literature
Unknown A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques.
| S-EPMC9802654 | biostudies-literature
Unknown Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.
| S-EPMC8373608 | biostudies-literature
Unknown An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques.
| S-EPMC7442803 | biostudies-literature
Transcriptomics A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques
2022-02-10 | GSE193264 | GEO
Unknown A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques.
| S-EPMC8158516 | biostudies-literature